BamSEC and AlphaSense Join Forces
Learn More

Hepion Pharmaceuticals Inc.

NASDAQ: HEPA    
Share price (1/8/25): $0.56    
Market cap (1/8/25): $3.899 million

Articles of Incorporation Filter

EX-3.1
from 8-K 1 page Certificate of Amendment to the Certificate of Incorporation of Hepion Pharmaceuticals, Inc
12/34/56
EX-3.4
from 8-K 3 pages Certificate of Amendment of Certificate of Designation of Preferences, Rights and Limitations, Which Have Not Been Set Forth in the Certificate of Incorporation or in Any Amendment Thereto, of the Series G Convertible Redeemable Preferred Stock of Hepion Pharmaceuticals, Inc. Pursuant to Section 151 of the General Corporation Law of the State of Delaware
12/34/56
EX-3.3
from 8-K 3 pages Certificate of Amendment of Certificate of Designation of Preferences, Rights and Limitations, Which Have Not Been Set Forth in the Certificate of Incorporation or in Any Amendment Thereto, of the Series F Convertible Redeemable Preferred Stock of Hepion Pharmaceuticals, Inc. Pursuant to Section 151 of the General Corporation Law of the State of Delaware
12/34/56
EX-3.2
from 8-K 22 pages Hepion Pharmaceuticals, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series G Convertible Redeemable Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.1
from 8-K 22 pages Hepion Pharmaceuticals, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series F Convertible Redeemable Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.1
from 8-K 1 page Amendment to the Bylaws of Hepion Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment to the Certificate of Incorporation of Contravir Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 18 pages Contravir Pharmaceuticals, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series E Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.1(G)
from S-1/A 17 pages Contravir Pharmaceuticals, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series E Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment of Certificate of Incorporation of Contravir Pharmaceuticals, Inc. Under Section 242 of the Delaware General Corporation Law
12/34/56
EX-3.1
from 8-K 18 pages Contravir Pharmaceuticals, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series D Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.1(E)
from S-1/A 18 pages Contravir Pharmaceuticals, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series D Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.1
from 8-K 20 pages Contravir Pharmaceuticals, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series C Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.1(D)
from S-1/A 19 pages Contravir Pharmaceuticals, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series C Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment of Certificate of Incorporation of Contravir Pharmaceuticals, Inc. Under Section 242 of the Delaware General Corporation Law
12/34/56
EX-3.1
from 8-K 14 pages Certificate of Designation, Preference and Rights of Series B Convertible Preferred Stock of Contravir Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 15 pages Certificate of Designation, Preference and Rights of Series a Convertible Preferred Stock of Contravir Pharmaceuticals, Inc
12/34/56
EX-3.2
from 10-12G 14 pages By-Laws of Contravir Pharmaceuticals, Inc. Effective as of May 15, 2013
12/34/56
EX-3.1
from 10-12G 5 pages I, Jeffrey W. Bullock, Secretary of State of the State of Delaware, Do Hereby Certify the Attached Is a True and Correct Copy of the Certificate of Incorporation of “Contravir Pharmaceuticals, Inc.”, Filed in This Office on the Fifteenth Day of May, A.D. 2013, at 1:17 O’ Clock P.M. a Filed Copy of This Certificate Has Been Forwarded to the Kent County Recorder of Deeds. 5335117 8100 /S/ Jeffrey W. Bullock Jeffrey W. Bullock, Secretary of State 130585678 Authentication: 0434764 You May Verify This Certificate Online at Corp. DELAWARE.GOV/AUTHVER.SHTML Date: 05-15-13 1 State of Delaware Secretary of State Division of Corporations Delivered 01:23 Pm 05/15/2013 Filed 01:17 Pm 05/15/2013 Srv 130585678 - 5335117 File Certificate of Incorporation of Contravir Pharmaceuticals, Inc
12/34/56